← Open Payments lookup

RACHEL BRIDGEMOHAN: Open Payments

NPI 1811240740 · BRISTOL, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,075 in 134 payments from 19 companies in 2025. Trend: 2023 $3,272 · 2024 $3,153 · 2025 $3,075

Food & beverage: $2,906Education: $169
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.20$486
Ardelyx, Inc.16$400
ABBVIE INC.21$384
Janssen Biotech, Inc.12$380
Salix Pharmaceuticals, a division of Bausch Health US, LLC18$352
Gilead Sciences, Inc.11$232
Madrigal Pharmaceuticals6$185
Intercept Pharmaceuticals, Inc.5$114
Lilly USA, LLC6$112
GENZYME CORPORATION3$73

Products named: IBSRELA, TREMFYA, ENTYVIO, XIFAXAN, REZDIFFRA, RINVOQ, GATTEX, OCALIVA.

Industry payments across CT — which companies pay providers there.